clinical trial · NCT06013306
Long-Term Follow-up Study of Subjects With Knee Osteoarthritis Who Had Administered FURESTEM-OA Kit Inj. in K0701 Study
Kang Stem Biotech Co., Ltd.·—·not yet recruiting·n = 58
Knee Osteoarthritis
brief summary
Long-Term Follow-up Study of Subjects with Knee Osteoarthritis who had administered FURESTEM-OA Kit Inj. in K0701 study
started
Sep 14, 2023
primary completion
Nov 7, 2029
completion
Dec 30, 2030
last updated
Aug 30, 2023
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol